Microbead electrochemiluminescence immunoassay for detection and identification of Venezuelan equine encephalitis virus.

This research paper presents the development of a high-sensitivity electrochemiluminescence immunoassay method for detecting and identifying Venezuelan equine encephalitis virus, a development that outperforms traditional detection methods in terms of speed and sensitivity.

Development of Electrochemiluminescence Immunoassay

• The researchers developed an electrochemiluminescence (ECL) immunoassay, a type of test that uses electrically charged light-emitting chemical reactions to detect and identify specific molecular substance—in this case, the Venezuelan equine encephalitis virus (VEEV).
• The test involves the use of chemically biotinylated and ruthenylated antibodies, which have been carefully selected from a pool of available monoclonal and polyclonal reagents.
• An optimized version of the assay was able to detect as few as 10^3pfu/ml of the VEEV TC-83 strain and 1 nanogram per milliliter of a recombinant VEEV E2 protein, making it the most sensitive test for this virus reported in literature to date.

Better Performance Compared to Existing Techniques

• The ECL immunoassay outmatches a conventional test method called the enzyme-linked immunosorbent assay (ELISA), showing a sensitivity the equivalent of one logarithmic unit higher. This indicates a significant improvement in detecting lower concentrations of VEEV.
• The ECL assay also outperforms ELISA in terms of test speed, providing results in approximately one hour as opposed to the the 6-8 hours required by ELISA.
• The variability of the ECL assays completed over time by different people showed that the ECL methods were consistent, with minimal variations in results.

Capability and Limitations

• The VEEV ECL assay was specific for VEEV, with no cross-reactivity detected with two closely related alphaviruses or 21 other different biological agents.
• Another variant of the ECL assay using a genetically biotinylated recombinant VEEV antibody instead of the chemically biotinylated one was also evaluated. While this test was functionally similar, it had a lower limit of detection, indicating it was less sensitive.

Conclusion

• This research successfully developed an ECL immunoassay for rapid, efficient and sensitive detection and identification of VEEV, showcasing considerable improvements over traditional methods such as the ELISA.